QQQ   271.64 (-3.90%)
AAPL   111.20 (-4.63%)
MSFT   202.68 (-4.96%)
FB   267.67 (-5.51%)
GOOGL   1,510.80 (-5.51%)
AMZN   3,162.78 (-3.76%)
TSLA   406.02 (-4.39%)
NVDA   505.08 (-5.75%)
BABA   307.94 (-2.90%)
CGC   18.34 (-1.71%)
GE   7.42 (+4.51%)
MU   50.00 (-3.77%)
AMD   76.40 (-3.14%)
T   26.50 (-1.56%)
F   7.70 (-2.78%)
ACB   3.83 (-4.25%)
GILD   58.72 (-2.15%)
NFLX   486.24 (-0.55%)
NIO   27.51 (-3.27%)
BA   148.14 (-4.57%)
DIS   118.47 (-3.93%)
QQQ   271.64 (-3.90%)
AAPL   111.20 (-4.63%)
MSFT   202.68 (-4.96%)
FB   267.67 (-5.51%)
GOOGL   1,510.80 (-5.51%)
AMZN   3,162.78 (-3.76%)
TSLA   406.02 (-4.39%)
NVDA   505.08 (-5.75%)
BABA   307.94 (-2.90%)
CGC   18.34 (-1.71%)
GE   7.42 (+4.51%)
MU   50.00 (-3.77%)
AMD   76.40 (-3.14%)
T   26.50 (-1.56%)
F   7.70 (-2.78%)
ACB   3.83 (-4.25%)
GILD   58.72 (-2.15%)
NFLX   486.24 (-0.55%)
NIO   27.51 (-3.27%)
BA   148.14 (-4.57%)
DIS   118.47 (-3.93%)
QQQ   271.64 (-3.90%)
AAPL   111.20 (-4.63%)
MSFT   202.68 (-4.96%)
FB   267.67 (-5.51%)
GOOGL   1,510.80 (-5.51%)
AMZN   3,162.78 (-3.76%)
TSLA   406.02 (-4.39%)
NVDA   505.08 (-5.75%)
BABA   307.94 (-2.90%)
CGC   18.34 (-1.71%)
GE   7.42 (+4.51%)
MU   50.00 (-3.77%)
AMD   76.40 (-3.14%)
T   26.50 (-1.56%)
F   7.70 (-2.78%)
ACB   3.83 (-4.25%)
GILD   58.72 (-2.15%)
NFLX   486.24 (-0.55%)
NIO   27.51 (-3.27%)
BA   148.14 (-4.57%)
DIS   118.47 (-3.93%)
QQQ   271.64 (-3.90%)
AAPL   111.20 (-4.63%)
MSFT   202.68 (-4.96%)
FB   267.67 (-5.51%)
GOOGL   1,510.80 (-5.51%)
AMZN   3,162.78 (-3.76%)
TSLA   406.02 (-4.39%)
NVDA   505.08 (-5.75%)
BABA   307.94 (-2.90%)
CGC   18.34 (-1.71%)
GE   7.42 (+4.51%)
MU   50.00 (-3.77%)
AMD   76.40 (-3.14%)
T   26.50 (-1.56%)
F   7.70 (-2.78%)
ACB   3.83 (-4.25%)
GILD   58.72 (-2.15%)
NFLX   486.24 (-0.55%)
NIO   27.51 (-3.27%)
BA   148.14 (-4.57%)
DIS   118.47 (-3.93%)
Log in
NASDAQ:XBIT

XBiotech News Headlines

$16.78
-1.08 (-6.05 %)
(As of 10/28/2020 12:00 AM ET)
Add
Compare
Today's Range
$16.73
Now: $16.78
$17.70
50-Day Range
$17.86
MA: $19.23
$21.16
52-Week Range
$8.72
Now: $16.78
$26.40
Volume93,699 shs
Average Volume394,532 shs
Market Capitalization$486.44 million
P/E Ratio1.16
Dividend YieldN/A
Beta1.5

Headlines

XBiotech (NASDAQ XBIT) News Headlines Today

Source:
SourceHeadline
Report: Austin among top emerging life science cities in US - Austin Business JournalReport: Austin among top emerging life science cities in US - Austin Business Journal
bizjournals.com - October 22 at 5:09 PM
XBiotech (NASDAQ:XBIT) Shares Up 8.7%XBiotech (NASDAQ:XBIT) Shares Up 8.7%
americanbankingnews.com - October 5 at 7:27 PM
What Kind Of Shareholders Hold The Majority In XBiotech Inc.s (NASDAQ:XBIT) Shares? - Yahoo FinanceWhat Kind Of Shareholders Hold The Majority In XBiotech Inc.'s (NASDAQ:XBIT) Shares? - Yahoo Finance
finance.yahoo.com - September 22 at 8:37 PM
XBiotech (XBIT) Developing True Human Antibody Combination as Candidate Treatment for Influenza-COVID-19 Co-Infections - StreetInsider.comXBiotech (XBIT) Developing True Human Antibody Combination as Candidate Treatment for Influenza-COVID-19 Co-Infections - StreetInsider.com
streetinsider.com - September 22 at 10:35 AM
XBiotech Developing True Human Antibody Combination as Candidate Treatment for Influenza-COVID-19 Co-Infections - GlobeNewswireXBiotech Developing True Human Antibody Combination as Candidate Treatment for Influenza-COVID-19 Co-Infections - GlobeNewswire
globenewswire.com - September 21 at 9:00 AM
XBiotech Developing True Human Antibody Combination as Candidate Treatment for Influenza-COVID-19 Co-InfectionsXBiotech Developing True Human Antibody Combination as Candidate Treatment for Influenza-COVID-19 Co-Infections
finance.yahoo.com - September 21 at 9:00 AM
NIH begs to differ on FDAs EUA for convalescent plasma for COVID-19 - Seeking AlphaNIH begs to differ on FDA's EUA for convalescent plasma for COVID-19 - Seeking Alpha
seekingalpha.com - September 1 at 7:54 PM
Austin experts weigh in on convalescent plasma after FDA authorization - Austin Business JournalAustin experts weigh in on convalescent plasma after FDA authorization - Austin Business Journal
bizjournals.com - August 27 at 11:42 PM
BUZZ-U.S. STOCKS ON THE MOVE-Apple Inc, Tesla Inc, XBiotech, Onconova Therapeutics - NasdaqBUZZ-U.S. STOCKS ON THE MOVE-Apple Inc, Tesla Inc, XBiotech, Onconova Therapeutics - Nasdaq
nasdaq.com - August 24 at 6:54 PM
Convalescent plasma players rally on FDA emergency use nod - Seeking AlphaConvalescent plasma players rally on FDA emergency use nod - Seeking Alpha
seekingalpha.com - August 24 at 8:54 AM
XBiotech (XBIT) -Developed COVID-19 Test Supports Convalescent Blood Treatments Now Approved Under FDA EUA - StreetInsider.comXBiotech (XBIT) -Developed COVID-19 Test Supports Convalescent Blood Treatments Now Approved Under FDA EUA - StreetInsider.com
streetinsider.com - August 24 at 8:54 AM
XBiotech-Developed COVID-19 Test Supports Convalescent Blood Treatments Now Approved Under FDA Emergency Use Authorization - GlobeNewswireXBiotech-Developed COVID-19 Test Supports Convalescent Blood Treatments Now Approved Under FDA Emergency Use Authorization - GlobeNewswire
globenewswire.com - August 24 at 8:54 AM
XBiotech-Developed COVID-19 Test Supports Convalescent Blood Treatments Now Approved Under FDA Emergency Use AuthorizationXBiotech-Developed COVID-19 Test Supports Convalescent Blood Treatments Now Approved Under FDA Emergency Use Authorization
finance.yahoo.com - August 24 at 8:54 AM
Convalescent plasma players under pressure on FDA hold on emergency use nod - Seeking AlphaConvalescent plasma players under pressure on FDA hold on emergency use nod - Seeking Alpha
seekingalpha.com - August 19 at 2:12 PM
Principia Bought By Sanofi, And Other News: The Good, Bad And Ugly Of Biopharma - Seeking AlphaPrincipia Bought By Sanofi, And Other News: The Good, Bad And Ugly Of Biopharma - Seeking Alpha
seekingalpha.com - August 18 at 4:11 AM
XBiotech Discovers COVID-19 Candidate Therapy; Stock Surges - NasdaqXBiotech Discovers COVID-19 Candidate Therapy; Stock Surges - Nasdaq
nasdaq.com - August 17 at 10:35 PM
XBiotech Discovers COVID-19 Candidate Therapy Nasdaq:XBIT - GlobeNewswireXBiotech Discovers COVID-19 Candidate Therapy Nasdaq:XBIT - GlobeNewswire
globenewswire.com - August 17 at 12:34 PM
Convalescent plasma players rally on positive results from COVID-19 study - Seeking AlphaConvalescent plasma players rally on positive results from COVID-19 study - Seeking Alpha
seekingalpha.com - August 13 at 6:17 PM
XBiotech Inc.: XBiotech and BioBridge Global Collaborate on FDA Program to Develop Potential COVID-19 Treatment Based on NaturalXBiotech Inc.: XBiotech and BioBridge Global Collaborate on FDA Program to Develop Potential COVID-19 Treatment Based on Natural
bloomberg.com - August 6 at 4:05 AM
5 Value Stocks In The Healthcare Sector - Benzinga5 Value Stocks In The Healthcare Sector - Benzinga
benzinga.com - August 3 at 6:38 PM
XBiotech: Well Funded, Working On The Next Bermekimab, And Undervalued - Seeking AlphaXBiotech: Well Funded, Working On The Next Bermekimab, And Undervalued - Seeking Alpha
seekingalpha.com - July 31 at 12:56 PM
Grifols delivers first batch of hyperimmune globulin for COVID-19 studies - Seeking AlphaGrifols delivers first batch of hyperimmune globulin for COVID-19 studies - Seeking Alpha
seekingalpha.com - July 28 at 3:28 PM
XBiotech Inc.: XBiotech Achieves Milestone for Production of its New Potential Blockbuster Anti-IL-1? TherapyXBiotech Inc.: XBiotech Achieves Milestone for Production of its New Potential Blockbuster Anti-IL-1? Therapy
www.finanznachrichten.de - July 24 at 7:15 AM
XBiotech Achieves Milestone for Production of its New Potential Blockbuster Anti-IL-1a TherapyXBiotech Achieves Milestone for Production of its New Potential Blockbuster Anti-IL-1a Therapy
www.marketwatch.com - July 24 at 7:15 AM
7 Micro-Cap Stocks You May Want to Take a Chance On - Nasdaq7 Micro-Cap Stocks You May Want to Take a Chance On - Nasdaq
www.nasdaq.com - July 23 at 3:30 AM
XBiotech in the green on advancement of new anti-inflammatory antibody (NASDAQ:XBIT) - Seeking AlphaXBiotech in the green on advancement of new anti-inflammatory antibody (NASDAQ:XBIT) - Seeking Alpha
seekingalpha.com - July 22 at 12:22 PM
7 Micro-Cap Stocks You May Want to Take a Chance On - InvestorPlace7 Micro-Cap Stocks You May Want to Take a Chance On - InvestorPlace
investorplace.com - July 21 at 4:19 PM
XBiotech antibody shows potential for treating stroke-related brain injury - Seeking AlphaXBiotech antibody shows potential for treating stroke-related brain injury - Seeking Alpha
seekingalpha.com - July 14 at 12:00 PM
XBiotech Announces Discovery that Blocking Interleukin-1a Reduces Brain Injury and Neurological Deficit After StrokeXBiotech Announces Discovery that Blocking Interleukin-1a Reduces Brain Injury and Neurological Deficit After Stroke
finance.yahoo.com - July 14 at 12:00 PM
Hedge Funds Starting To Get Bullish On XBiotech Inc. (XBIT) - Yahoo FinanceHedge Funds Starting To Get Bullish On XBiotech Inc. (XBIT) - Yahoo Finance
finance.yahoo.com - June 22 at 3:00 PM
Hedge Funds Starting To Get Bullish On XBiotech Inc. (XBIT)Hedge Funds Starting To Get Bullish On XBiotech Inc. (XBIT)
finance.yahoo.com - June 22 at 2:59 PM
The List: Austin-area public company CEO compensation - Austin Business Journal - New York Business JournalThe List: Austin-area public company CEO compensation - Austin Business Journal - New York Business Journal
www.bizjournals.com - June 11 at 9:14 AM
XBiotech, Inc: XBiotech to Provide Fourth Quarter and Full Year 2016 Business UpdateXBiotech, Inc: XBiotech to Provide Fourth Quarter and Full Year 2016 Business Update
www.bloomberg.com - June 7 at 5:18 PM
BRIEF-Xbiotech - Announced That Human Immune Donors Have Been Identified That Can Support Cos Development Of True Human Antibody Therapy For Covid-19 - ReutersBRIEF-Xbiotech - Announced That Human Immune Donors Have Been Identified That Can Support Co's Development Of True Human Antibody Therapy For Covid-19 - Reuters
www.reuters.com - May 1 at 9:21 PM
XBiotech advancing antibody therapy for COVID-19 - Seeking AlphaXBiotech advancing antibody therapy for COVID-19 - Seeking Alpha
seekingalpha.com - May 1 at 4:21 PM
XBiotech (XBIT) Identifies "Super Bloods" for Development of True Human COVID-19 Therapy - StreetInsider.comXBiotech (XBIT) Identifies "Super Bloods" for Development of True Human COVID-19 Therapy - StreetInsider.com
www.streetinsider.com - May 1 at 9:36 AM
XBiotech Identifies “Super Bloods” for the Development of a True Human™ COVID-19 TherapyXBiotech Identifies “Super Bloods” for the Development of a True Human™ COVID-19 Therapy
finance.yahoo.com - May 1 at 9:36 AM
Clinical trial launched testing convalescent plasma in COVID-19 patients - Seeking AlphaClinical trial launched testing convalescent plasma in COVID-19 patients - Seeking Alpha
seekingalpha.com - April 29 at 10:25 PM
7 Top Stocks to Buy for Aggressive Investors - Investorplace.com7 Top Stocks to Buy for Aggressive Investors - Investorplace.com
investorplace.com - April 27 at 2:21 PM
Could XBiotech’s Convalescent Plasma Program Make a Breakthrough in Treating COVID-19 Patients? - Yahoo FinanceCould XBiotech’s Convalescent Plasma Program Make a Breakthrough in Treating COVID-19 Patients? - Yahoo Finance
finance.yahoo.com - April 18 at 12:39 AM
XBiotech Developing Novel True Human Antibody Targeting Interleukin-1alpha (IL-1 ) - GlobeNewswireXBiotech Developing Novel True Human Antibody Targeting Interleukin-1alpha (IL-1 ) - GlobeNewswire
www.globenewswire.com - April 16 at 12:05 AM
BRIEF-XBiotech Developing Novel True Human Antibody Targeting Interleukin-1Alpha - ReutersBRIEF-XBiotech Developing Novel True Human Antibody Targeting Interleukin-1Alpha - Reuters
www.reuters.com - April 14 at 1:00 PM
XBiotech Developing Novel True Human Antibody Targeting Interleukin-1alpha (IL-1⍺) - Yahoo FinanceXBiotech Developing Novel True Human Antibody Targeting Interleukin-1alpha (IL-1⍺) - Yahoo Finance
finance.yahoo.com - April 14 at 1:00 PM
XBiotech Developing Novel True Human Antibody Targeting Interleukin-1alpha (IL-1⍺)XBiotech Developing Novel True Human Antibody Targeting Interleukin-1alpha (IL-1⍺)
finance.yahoo.com - April 14 at 1:00 PM
XBiotech Gains on FDA NodXBiotech Gains on FDA Nod
www.baystreet.ca - April 6 at 4:15 PM
A Peek Into The Markets: US Stock Futures Jump; Crude Oil Falls Over 3% - BenzingaA Peek Into The Markets: US Stock Futures Jump; Crude Oil Falls Over 3% - Benzinga
www.benzinga.com - April 6 at 7:04 AM
5 Stocks To Watch For April 6, 2020 - Benzinga5 Stocks To Watch For April 6, 2020 - Benzinga
www.benzinga.com - April 6 at 7:04 AM
FDA announces initiatives for antibody blood products for COVID-19 - Seeking AlphaFDA announces initiatives for antibody blood products for COVID-19 - Seeking Alpha
seekingalpha.com - April 3 at 9:12 PM
BRIEF-Xbiotech And Biobridge Global Collaborate On FDA Program To Develop Potential COVID-19 Treatment Based On Natural Antibodies From Recovered Patients - ReutersBRIEF-Xbiotech And Biobridge Global Collaborate On FDA Program To Develop Potential COVID-19 Treatment Based On Natural Antibodies From Recovered Patients - Reuters
www.reuters.com - April 3 at 9:12 PM
XBiotech and BioBridge Global Collaborate on FDA Program to Develop Potential COVID-19 Treatment Based on Natural Antibodies from Recovered Patients - GlobeNewswireXBiotech and BioBridge Global Collaborate on FDA Program to Develop Potential COVID-19 Treatment Based on Natural Antibodies from Recovered Patients - GlobeNewswire
www.globenewswire.com - April 3 at 9:12 PM
This page was last updated on 10/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.